Therapeutic options in severe thyrotoxicosis with malabsorption

2017 ◽  
Author(s):  
Mirjana Stojkovic ◽  
Slavica Savic ◽  
Biljana Nedeljkovic-Beleslin ◽  
Jasmina Ciric ◽  
Tanja Nisic ◽  
...  
Keyword(s):  
Therapeutic Options

Therapeutic options in patients with malignant biliary obstruction – a retrospective single center analyze

2016 ◽  
Vol 54 (05) ◽  
Author(s):  
R Schwarzer ◽  
S Hametner ◽  
A Ziachehabi ◽  
S Gerstl ◽  
R Függer ◽  
...  
Keyword(s):  
Biliary Obstruction ◽  
Malignant Biliary Obstruction ◽  
Therapeutic Options ◽  
Single Center

Therapeutic options for Grave's disease and toxic nodular disease: experience of an endocrinology department

2014 ◽  
Author(s):  
Joao Silva ◽  
Mafalda Marcelino ◽  
Ana Lopes ◽  
Luis Lopes ◽  
Dolores Passos ◽  
...  
Keyword(s):  
Therapeutic Options ◽  
Grave’S Disease ◽  
Grave's Disease ◽  
Disease Experience

Therapeutic options in metastatic phaeochromocytomas

2017 ◽  
Author(s):  
Edouard Mills ◽  
Roberto Dina ◽  
Fausto Palazzo ◽  
Rohini Sharma ◽  
Florian Wernig
Keyword(s):  
Therapeutic Options

Molecular events in a large series of advanced stage III-IV adrenocortical cancer: looking for new therapeutic options

2019 ◽  
Author(s):  
Martino Maria Cristina De ◽  
Ludovic Lacroix ◽  
Sebastien Aubert ◽  
Rossella Libe ◽  
Ghuzlan Abir Al ◽  
...  
Keyword(s):  
Large Series ◽  
Therapeutic Options ◽  
Stage Iii ◽  
Advanced Stage ◽  
Adrenocortical Cancer ◽  
Molecular Events

Biological therapy in idiopathic inflammatory myopathies

2014 ◽  
Vol 155 (1) ◽  
pp. 3-10
Author(s):  
Levente Bodoki ◽  
Melinda Nagy-Vincze ◽  
Zoltán Griger ◽  
Andrea Péter ◽  
Csilla András ◽  
...  
Keyword(s):  
T Cells ◽  
Muscle Weakness ◽  
Biological Therapy ◽  
Therapeutic Options ◽  
Idiopathic Inflammatory Myopathies ◽  
Inflammatory Myopathies ◽  
Progressive Muscle Weakness ◽  
Immune Mediated ◽  
Novel Therapeutic

Idiopathic inflammatory myopathies are systemic, immune-mediated diseases characterized by proximal, symmetrical, progressive muscle weakness. The aim of this work is to give an overview of the biological therapy used in the treatment of idiopathic inflammatory myopathies. The authors also focus on novel results in the therapy directed against the B- and T-cells. They emphasize the importance of new trials in these diseases which may lead to the introduction of novel therapeutic options in these disorders. Orv. Hetil., 2014, 155(1), 3–10.

Sign in / Sign up

Export Citation Format

Share Document